Spiro Kevin Sakiris, the Chief Financial Officer of Intelligent Bio Solutions (INBS), engaged in a stock transaction on March 20, 2024, as per the latest SEC filings. Sakiris acquired 9,394 shares of Intelligent Bio Solutions' common stock indirectly through Anest Holdings Pty Ltd, with the transaction coded as 'X'. Following this acquisition, Sakiris now indirectly holds a total of 19,180 shares. Additionally, he directly holds 314 shares of common stock. The nature of the shares acquired is indirect, and the transaction has increased his total beneficial ownership in the company to 19,494 shares.

Spiro Kevin Sakiris, the Chief Financial Officer of Intelligent Bio Solutions (INBS), engaged in a stock transaction on March 20, 2024, as per the latest SEC filings. Sakiris acquired 9,394 shares of Intelligent Bio Solutions' common stock indirectly through Anest Holdings Pty Ltd, with the transaction coded as 'X'. Following this acquisition, Sakiris now indirectly holds a total of 19,180 shares. Additionally, he directly holds 314 shares of common stock. The nature of the shares acquired is indirect, and the transaction has increased his total beneficial ownership in the company to 19,494 shares.